Ruzicka Daniel J, Eichinger Walter B, Hettich Ina M, Bleiziffer Sabine, Bauernschmitt Robert, Lange Ruediger
German Heart Center Munich, Department of Cardiovascular Surgery, Munich, Germany.
J Heart Valve Dis. 2008 Jul;17(4):426-33; discussion 434.
The St. Jude Medical Epic Supra (ES) valve is a new porcine bioprosthesis designed for complete supra-annular implantation. To date, no in-vivo data regarding the hemodynamic and clinical performance of this valve are available. The study aim was to compare the hemodynamic performance of the ES valve with the completely supra-annular Medtronic Mosaic (MM) porcine valve.
Between July 2000 and April 2006, 83 patients (39 males, 44 females) underwent aortic valve replacement with either the ES (n = 44) or MM (n = 39) bioprosthesis. Hemodynamic performance was evaluated echocardiographically at six months postoperatively. Comparison between the valves was performed by dividing the patient groups according to their intraoperatively measured tissue annulus diameter rather than the labeled valve size.
The internal diameter and sewing ring diameter differed in ES and MM valves with the same labeled size. For example, in valves labeled '23' the internal diameter/sewing ring diameters were 21.5 and 29.3 mm in the ES valve versus 20.5 and 30 mm in the MM. The mean pressure gradients (MPG) for patients with ES or MM valves were 15.5 +/- 4.5 or 14.8 +/- 5.1 mmHg for annulus diameter < or =22 mm, 14.6 +/- 6.4 or 13.9 +/- 3.6 for annulus diameter 23-24 mm, and 15.3 +/- 3.8 or 13.4 +/- 4.2 mmHg for annulus diameter > or =25 mm. No significant differences were identified in the hemodynamic data, including MPG, effective orifice area (EOA) and effective orifice area index (EOAI). The incidence of moderate or severe patient-prosthesis mismatch (PPM) was 40% (n = 18) and 5% (n = 1) in patients with ES valves, and 26% (n = 10) or 23% (n = 9) in patients with MM valves (p = 0.01). In patients with an annulus size < or =22 mm, severe PPM occurred in 29% (n =5) of patients with MM valves but in none of those with ES valves.
The hemodynamic performance of the ES valve was comparable to that of the well-established MM valve. The incidence of severe PPM was lower in patients with ES valves than MM valves, presumably due to the somewhat larger EOA values in patients with a small aortic annulus (<25 mm).
圣犹达医疗公司的Epic Supra(ES)瓣膜是一种新型猪生物假体,设计用于完全瓣环上植入。迄今为止,尚无关于该瓣膜血流动力学和临床性能的体内数据。本研究的目的是比较ES瓣膜与完全瓣环上的美敦力Mosaic(MM)猪瓣膜的血流动力学性能。
2000年7月至2006年4月期间,83例患者(39例男性,44例女性)接受了ES(n = 44)或MM(n = 39)生物假体主动脉瓣置换术。术后6个月通过超声心动图评估血流动力学性能。根据术中测量的组织瓣环直径而非标记的瓣膜尺寸将患者分组,对瓣膜进行比较。
相同标记尺寸的ES和MM瓣膜的内径和缝合环直径不同。例如,标记为“23”的瓣膜中,ES瓣膜的内径/缝合环直径为21.5和29.3 mm,而MM瓣膜为20.5和30 mm。瓣环直径≤22 mm的ES或MM瓣膜患者的平均压力阶差(MPG)分别为15.5±4.5或14.8±5.1 mmHg,瓣环直径23 - 24 mm时为14.6±6.4或13.9±3.6 mmHg,瓣环直径≥25 mm时为15.3±3.8或13.4±4.2 mmHg。在包括MPG、有效瓣口面积(EOA)和有效瓣口面积指数(EOAI)在内的血流动力学数据中未发现显著差异。ES瓣膜患者中中度或重度患者-假体不匹配(PPM)的发生率为40%(n = 18)和5%(n = 1),MM瓣膜患者中为26%(n = 10)或23%(n = 9)(p = 0.01)。在瓣环尺寸≤22 mm的患者中,MM瓣膜患者中有29%(n = 5)发生严重PPM,而ES瓣膜患者中无此情况。
ES瓣膜的血流动力学性能与成熟的MM瓣膜相当。ES瓣膜患者中严重PPM的发生率低于MM瓣膜,可能是由于小主动脉瓣环(<25 mm)患者的EOA值略大。